- /
- Supported exchanges
- / US
- / PFSA.NASDAQ
Profusa, Inc. Common Stock (PFSA NASDAQ) stock market data APIs
Profusa, Inc. Common Stock Financial Data Overview
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Profusa, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Profusa, Inc. Common Stock data using free add-ons & libraries
Get Profusa, Inc. Common Stock Fundamental Data
Profusa, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -922
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Profusa, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-08-19
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Profusa, Inc. Common Stock News
New
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
Profusa, Inc. Berkeley, CA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) (the "Company") announced that it has received a letter (the "Notice") from the Listing Qualifications Depar...
Profusa Announces 1-for-4 Reverse Stock Split
Profusa, Inc. BERKELEY, California, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation...
Profusa vies for potential G3 Vision Labs acquisition
Digital health specialist Profusa has inked an option agreement to acquire G3 Vision Labs and its subsidiaries, giving the company a route to add an arsenal of diagnostics to its commercial portfolio....
Profusa Enters Option Agreement To Acquire G3 Vision Labs; Shares Plunge
(RTTNews) - Profusa, Inc. (PFSA), a digital health company, announced the signing of an option agreement that provides Profusa the right and option to acquire G3 Vision Labs, Inc. and its subsidiaries...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.